Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.

Zhong W, Wang X, Pan B, Su Z.

Tumour Biol. 2014 Oct;35(10):9839-45. doi: 10.1007/s13277-014-2194-4. Epub 2014 Jul 3.

PMID:
24989926
2.
3.

Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.

Lu G, Dong Y, Zhang Q, Jiao L, Yang S, Shen B.

Tumour Biol. 2015 Nov;36(11):8645-52. doi: 10.1007/s13277-015-3431-1. Epub 2015 Jun 5.

PMID:
26044558
4.

VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.

Sáenz-López P, Vazquez F, Cozar JM, Carretero R, Garrido F, Ruiz-Cabello F.

Hum Immunol. 2013 Jan;74(1):98-103. doi: 10.1016/j.humimm.2012.10.014. Epub 2012 Oct 13.

PMID:
23073296
5.

Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.

Xian W, Zheng H, Wu WJ.

Genet Mol Res. 2015 Jul 13;14(3):7634-42. doi: 10.4238/2015.July.13.8.

6.

Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.

Yang YQ, Chen J.

Genet Mol Res. 2014 Jul 4;13(3):5011-7. doi: 10.4238/2014.July.4.16.

7.

Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.

Jang MJ, Kim JW, Jeon YJ, Chong SY, Oh D, Kim NK.

Int J Clin Oncol. 2013 Dec;18(6):1032-41. doi: 10.1007/s10147-012-0493-6. Epub 2012 Nov 7.

PMID:
23132736
8.

The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.

Oh SY, Kwon HC, Kim SH, Lee S, Lee JH, Hwang JA, Hong SH, Graves CA, Camphausen K, Kim HJ, Lee YS.

BMC Cancer. 2013 Feb 1;13:43. doi: 10.1186/1471-2407-13-43.

9.

Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.

Jang MJ, Jeon YJ, Kim JW, Cho YK, Lee SK, Hwang SG, Oh D, Kim NK.

Mol Carcinog. 2013 Nov;52 Suppl 1:E60-9. doi: 10.1002/mc.21980. Epub 2012 Nov 20.

PMID:
23169005
10.

Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.

Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, Karakitsos P.

Mol Carcinog. 2009 Jun;48(6):563-9. doi: 10.1002/mc.20495.

PMID:
19009560
11.

Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.

Liu GX, Zhang X, Li S, Koiiche RD, Sindsceii JH, Song H.

Tumour Biol. 2013 Oct;34(5):2741-6. doi: 10.1007/s13277-013-0827-7. Epub 2013 May 9.

PMID:
23657965
12.

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.

Masago K, Fujita S, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Ichikawa M, Mio T, Mishima M.

Cancer Sci. 2009 Oct;100(10):1917-22. doi: 10.1111/j.1349-7006.2009.01253.x. Epub 2009 Jun 23.

13.

The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.

Qin C, Cao Q, Ju X, Wang M, Meng X, Zhu J, Yan F, Li P, Ding Q, Chen J, Gu M, Zhang W, Yin C, Zhang Z.

Ann Oncol. 2012 Apr;23(4):981-9. doi: 10.1093/annonc/mdr325. Epub 2011 Jul 21.

14.

Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.

Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, Kummalue T, Rojananin S, Ratanawichhitrasin A, Prasarttong-Osoth P, Chuthatisith S, Pisarnturakit P, Aeumrithaicharoenchok W, Rushatamukayanunt P, Lohsiriwat V, Boonsripitayanon M, Malasit P, O-Charoenrat P.

Mol Med Rep. 2013 Oct;8(4):1242-50. doi: 10.3892/mmr.2013.1607. Epub 2013 Jul 31.

PMID:
23904001
15.

Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.

Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun SH.

Clin Cancer Res. 2008 Jan 1;14(1):62-6. doi: 10.1158/1078-0432.CCR-07-1537.

16.

Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.

Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, Pikoulis E, Tsigris C, Karakitsos P, Peros G, Nikiteas N.

J Surg Oncol. 2006 Dec 1;94(7):624-30.

PMID:
17111394
17.

Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.

Ajaz S, Khaliq S, Abid A, Hassan AS, Hashmi A, Sultan G, Mohsin R, Mubarrak M, Naqvi SA, Rizvi SA, Mehdi SQ.

Genet Test Mol Biomarkers. 2011 Sep;15(9):653-7. doi: 10.1089/gtmb.2011.0029. Epub 2011 Apr 14.

PMID:
21491998
18.

Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.

Cai C, Wang LH, Dong Q, Wu ZJ, Li MY, Sun YH.

Tissue Antigens. 2013 Sep;82(3):165-70. doi: 10.1111/tan.12170.

PMID:
24032722
19.

Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.

Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B.

Mol Carcinog. 2009 Dec;48(12):1170-6. doi: 10.1002/mc.20572.

PMID:
19676106
20.

Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis.

Deng ZC, Cao C, Yu YM, Ma HY, Ye M.

Tumour Biol. 2014 Mar;35(3):1805-11. doi: 10.1007/s13277-013-1241-x. Epub 2013 Oct 22.

PMID:
24146275
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk